NAION and Semaglutide: New Research Findings Recent studies have shed light on a potential link between semaglutide use and an increased risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Cagrilintide is a long-acting acylated amylin analogue, a dual amylin and calcitonin receptor agonist that hits the AMY1, AMY2 and AMY3 receptor complexes plus the calcitonin receptor, mainly in the area postrema and hindbrain
Marketed as a convenient, needle-free alternative to the in-demand injectables, these patches claim to help people lose weight without injections or prescriptions
This age-related decline is particularly intriguing, as GHK-Cu is known to play a vital role in numerous biological processes, especially those related to skin health and tissue regeneration
doi: 10.3389/fendo.2026.1709556 Received 23 September 2025 Revised 15 January 2026 Accepted 26 January 2026 Published 11 February 2026 Volume 17 - 2026 Edited by Abdel Halim Harrath, King Saud University, Saudi Arabia Reviewed by Aldo Ferreira-Hermosillo, Mexican Social Security Institute, Mexico Raquel Evelyn Horowitz, Montefiore Medical Center, United States Updates Copyright 2026 Wang, Chen, Wang, Song and Zhang